Fiche publication
Date publication
septembre 2006
Journal
European journal of cancer care
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRIANCON Serge
,
Pr GUILLEMIN Francis
,
Pr MARTINET Yves
Tous les auteurs :
Alzahouri K, Martinet Y, Briançon S, Guillemin F
Lien Pubmed
Résumé
Lung cancer is the most frequent cause of cancer deaths worldwide, and non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all cases. Stage at diagnosis is the most important indicator of survival. Various non-invasive and invasive procedures are available for NSCLC staging. However, the precise indications for performing these procedures remain controversial. There is no evidence about the level of variability in practice of imaging and invasive procedures used for NSCLC staging. Their high costs contribute to the controversy about their use. We performed a literature search on the MEDLINE database to identify studies reporting practice of staging for a nonselected group of patients with NSCLC. Only seven studies enrolling between 185 and 2,071 patients reported NSCLC staging practices. These studies were reviewed to identify patterns in practice of staging work-up and consecutive treatment. Lack of detailed reporting limits the interpretation of the results. Based on our review, future investigations should be conducted to determine the extent of variation in patterns of physician practices of NSCLC staging and their impact on the treatment practice or patient survival.
Mots clés
Carcinoma, Non-Small-Cell Lung, pathology, Humans, Lung Neoplasms, pathology, Neoplasm Staging, methods
Référence
Eur J Cancer Care (Engl). 2006 Sep;15(4):348-54
